Holen Sie sich die Stockscreener-App
186.23
1.78%
-3.37
Handel nachbörslich:
194.70
8.47
+4.55%
Schlusskurs vom Vortag:
$189.60
Offen:
$187.9
24-Stunden-Volumen:
3.07M
Relative Volume:
1.25
Marktkapitalisierung:
$39.36B
Einnahmen:
$447.02M
Nettoeinkommen (Verlust:
$-1.18B
KGV:
-30.13
EPS:
-6.1812
Netto-Cashflow:
$-868.57M
1W Leistung:
+13.54%
1M Leistung:
+18.50%
6M Leistung:
+157.58%
1J Leistung:
+172.58%
1-Tages-Spanne:
$178.76
$188.56
1-Wochen-Bereich:
$163.11
$197.08
52-Wochen-Spanne:
$60.40
$197.08
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-28 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
Building trade automation scripts for Insmed IncorporatedBuy Signal & Technical Pattern Based Signals - newser.com
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3 - Yahoo Finance
Trend analysis for Insmed Incorporated this weekJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - newser.com
Insmed discovers new cathepsin C inhibitors - BioWorld MedTech
Is Insmed Incorporated (IM8N) stock a buy before new product rollout2025 Market Outlook & Weekly High Momentum Picks - newser.com
Historical volatility pattern of Insmed Incorporated visualized2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
Will Insmed Incorporated stock benefit from automationJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com
Can Insmed Incorporated stock deliver surprise earnings beatTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com
Why Insmed Incorporated is moving todayDay Trade & Community Consensus Trade Alerts - newser.com
How Insmed Incorporated stock reacts to Fed rate cutsGap Down & Daily Profit Maximizing Tips - newser.com
Earnings Beat: Insmed Incorporated (NASDAQ:INSM) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
What dividend safety score for Insmed Incorporated stock2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Insmed, Inc. $INSM Position Reduced by Moody Aldrich Partners LLC - MarketBeat
Envestnet Asset Management Inc. Acquires 40,520 Shares of Insmed, Inc. $INSM - MarketBeat
What machine learning models say about Insmed IncorporatedLayoff News & Real-Time Volume Surge Alerts - newser.com
Insmed Incorporated (NASDAQ:INSM) Q3 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Maintains Insmed (INSM) Overweight Recommendation - Nasdaq
Insmed Inc (INSM) Stock Price, Trades & News - GuruFocus
Insmed (NASDAQ:INSM) Posts Earnings Results, Misses Estimates By $0.40 EPS - MarketBeat
Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq
Insmed Incorporated (INSM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Wells Fargo Raises Price Target for INSM to $217, Maintains Over - GuruFocus
Insmed (NASDAQ:INSM) Hits New 12-Month HighTime to Buy? - MarketBeat
Goldman Sachs Boosts Insmed (INSM) Price Target to $225 | INSM S - GuruFocus
INSM: UBS Maintains 'Buy', Raises Price Target to $223 | INSM St - GuruFocus
Insmed Shares Likely to Gain From Brinsupri Sales, Untapped Pipeline, UBS Says - MarketScreener
Insmed stock surges as UBS raises price target on Brinsupri launch success - Investing.com Canada
Insmed (INSM) Sees Price Target Raised by RBC Capital to $215 | - GuruFocus
Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook - Insider Monkey
Insmed Q3 2025 slides reveal strong BRINSUPRI debut, ARIKAYCE growth accelerates - Investing.com Australia
Insmed stock hits 52-week high at 170.3 USD By Investing.com - Investing.com Australia
RBC Raises Price Target on Insmed to $215 From $139, Keeps Outperform Rating - MarketScreener
Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake - TradingView
Cantor Fitzgerald Comments on Insmed FY2025 Earnings - MarketBeat
UBS Adjusts Insmed Price Target to $223 From $194, Maintains Buy Rating - MarketScreener
Truist Raises Price Target on Insmed to $214 From $139, Keeps Buy Rating - MarketScreener
Insmed: Q3 Earnings Snapshot - Stamford Advocate
Emerald Mutual Fund Advisers Trust Sells 328,407 Shares of Insmed, Inc. $INSM - MarketBeat
Emerald Advisers LLC Decreases Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Reaches Analyst Target Price - Nasdaq
Insmed, Inc. $INSM Shares Sold by Jennison Associates LLC - MarketBeat
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
Is Insmed Incorporated (IM8N) stock among top earnings playsPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com
Insmed Q3 2025 Earnings Call Transcript - MarketBeat
Insmed earnings missed by $0.41, revenue topped estimates - Investing.com Canada
Will Insmed Incorporated (IM8N) stock see valuation expansionEarnings Growth Report & Free Fast Gain Swing Trade Alerts - newser.com
Will Insmed Incorporated stock outperform Dow Jones indexJuly 2025 Update & Real-Time Chart Pattern Alerts - newser.com
A Look at Insmed (INSM) Valuation Following EU Brensocatib Milestone and ARIKAYCE Revenue Upgrade - Yahoo Finance
Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus
Insmed stock price target raised to $223 by TD Cowen on strong Brinsupri launch - Investing.com Nigeria
Insmed Inc (INSM) Q3 2025 Earnings Call Highlights: Strong Launch for Brin Suri and Robust ... By GuruFocus - Investing.com Canada
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.44%
4.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):